Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Invion ( (AU:IVX) ).
Invion Limited has announced the quotation of 7,250,269 fully paid ordinary securities on the Australian Securities Exchange (ASX), with an issue date of May 12, 2025. This move is part of previously announced transactions, potentially enhancing the company’s financial flexibility and market presence.
More about Invion
Invion Limited operates within the biotechnology industry, focusing on the development and commercialization of treatments for chronic inflammatory diseases. The company is primarily involved in research and development activities aimed at innovative therapeutic solutions.
YTD Price Performance: -71.43%
Average Trading Volume: 84,473
Technical Sentiment Signal: Sell
Current Market Cap: A$6.2M
Learn more about IVX stock on TipRanks’ Stock Analysis page.